A9606 HCPCS code: Radium ra-223 dichloride, therapeutic, per microcurie
A9606 is the HCPCS Level II code for radium ra-223 dichloride, therapeutic, per microcurie. In 2024 Medicare paid an average of $137.73 per service for A9606 across 132,313 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 224 per day on outpatient hospital claims. Medicare volume fell 44% from 2022 to 2024 (237,613 to 132,313 services). In 2024, about 155 clinicians billed Medicare for A9606 for 297 beneficiaries; Florida, Maryland, Texas accounted for 44% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2015-01-01 |
| Last action effective | 2025-01-01 |
Who bills A9606 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 155 |
| Medicare beneficiaries | 297 |
| States with claims | 11 |
| Share of services in top 3 states (Florida, Maryland, Texas) | 44% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9606, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 237,613 | 541 | $158.41 | $126.44 |
| 2023 | 164,321 | 370 | $161.22 | $128.44 |
| 2024 | 132,313 | 297 | $172.88 | $137.73 |
States with the most A9606 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 16,077 | $136.04 |
| Maryland | 13,771 | $132.63 |
| Texas | 13,181 | $138.42 |
| Arizona | 10,837 | $138.63 |
| California | 10,517 | $141.08 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 224 | Prescribing Information |
| practitioner claims | 224 | Prescribing Information |
Medicare policy articles for this code
- A54559: Billing and Coding: Xofigo Billing Instructions (Palmetto GBA (MAC - Part B))
Covered diagnoses (3 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| C61 | Malignant neoplasm of prostate | 1 |
| C79.51 | Secondary malignant neoplasm of bone | 1 |
| C79.52 | Secondary malignant neoplasm of bone marrow | 1 |
What changed for A9606
- 2015-01-01: A9606 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9606?
A9606 is the HCPCS Level II code for radium ra-223 dichloride, therapeutic, per microcurie. Short descriptor: "Radium ra223 dichloride ther".
How much does Medicare pay for A9606?
In 2024, the average Medicare payment was $137.73 per service (average allowed $172.88).
Does Medicare cover A9606?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for A9606?
Medicare policy articles that cite A9606 list 3 covered ICD-10-CM diagnosis codes across 1 article. The most cited include C61 (Malignant neoplasm of prostate), C79.51 (Secondary malignant neoplasm of bone), C79.52 (Secondary malignant neoplasm of bone marrow). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of A9606 can be billed per day?
224 on outpatient hospital claims; 224 on practitioner claims (NCCI medically unlikely edits).
Related A96 codes
- A9600 — Strontium sr-89 chloride, therapeutic, per millicurie
- A9601 — Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602 — Fluorodopa f-18, diagnostic, per millicurie
- A9603 — Injection, pafolacianine, 0.1 mg
- A9604 — Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9607 — Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
- A9608 — Flotufolastat f 18, diagnostic, 1 millicurie
- A9609 — Fludeoxyglucose f18 up to 15 millicuries
- A9610 — Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- A9611 — Flurpiridaz f 18, diagnostic, 1 millicurie
- A9612 — Injection, fluorescein, 1 mg
- A9613 — Piflufolastat f 18 (pylarify truvu), diagnostic, 1 millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9606
- Watch A9606 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9606
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.